VVOS
NASDAQ
$0.41
Vivos Therapeutics Inc (VVOS)
Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered breathing, such as mild to moderate obstructive sleep apnea (OSA). The company is headquartered in Highlands Ranch, Colorado.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $2.12 (+414.83%)
Market Cap
$5.57M
Beta (5Y)
0.81
Price Chart
Valuation
Market Cap$5.57M
P/S0.29
P/B6.86
Profitability
Total Revenue (TTM)$20M
Gross Profit (TTM)$12M
EBITDA-$21M
Profit Margin-127.7%
Operating Margin-128.7%
EPS-$2.65
Financial Health
Debt-to-Equity-678.1%
Growth & Risk
Revenue 5Y CAGR+8.41%
Beta (5Y)0.81
Sharpe Ratio-2.46